Trecetilide

DB19844ExperimentalSmall molecule

Trecetilide is a small molecule drug. The usage of the INN stem '-ilide' in the name indicates that Trecetilide is a sematilide derivative class III antiarrhythmic. Trecetilide has a monoisotopic...

Mechanism: Pharmacologically active on Voltage-gated inwardly rectifying potassium channel KCNH2
Curator reviewed
Formula / weight: C₂₁H₃₇FN₂O₃S · 416.6 g/mol (avg)

Resolves to

Compound

UNII3R7HJU91EJCAS180918-68-7ChEMBLCHEMBL269446ChEBI177812PubChem163300

Structure

InChIKeyRPQUKWBLAHJOPX-FQEVSTJZSA-NSMILESCCN(CCCCCC(C)(C)F)CCC[C@H](O)C1=CC=C(NS(C)(=O)=O)C=C1

Targets

Q12809KCNH2

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Trecetilide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account